Anzeige
Mehr »
Login
Dienstag, 21.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Aktienchance des Jahres! Ihre Chance auf explosive Gewinne!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
572 Leser
Artikel bewerten:
(2)

Averna Technologies Inc.: Averna Expands Global Footprint into Germany with the Acquisition of ProNES

Finanznachrichten News

ProNES brings specialized battery test and quality expertise to Averna.

MONTREAL, May 23, 2023 /PRNewswire/ -- Averna, the leading global Test & Quality Solutions provider, announced today they have acquired the German company ProNES Automation GmbH. ProNES has been helping manufacturers efficiently produce better products for over 20 years. In this time, they have developed hundreds of customized automated quality solutions as well as their flexible test platform, batterieinspektor. ProNES' current owner and CEO Jochen Weber will join the leadership team and oversee Averna sales and operations in Germany from the Landau office.

"We are proud to welcome ProNES' customers and employees while providing our customers with additional solutions and a localized presence in Germany." said Francois Rainville, Averna's President and CEO. "Jochen and the entire ProNES team have achieved truly impressive successes in automation and smart manufacturing within the test engineering and battery test markets. We are excited to add their expertise to support the growing number of global battery manufacturers and expand their reach with Averna's capacity."

The global battery manufacturing equipment market is projected to grow to around $31 billion USD by 2030, at an annual growth rate (CAGR) of 31.63% from this year. The demand for lithium-ion batteries is increasing for several reasons, including the increase of electric vehicles and the growing demand for energy storage.

By adding a new office in Landau, Averna is well positioned to provide their range of innovative automated test, vision inspection and precision assembly solutions to their German clients. With an extensive history of medical device, life science and pharma packaging test and validation, this new location is perfectly situated to serve Germany's notable medical technology community.

According to Jochen Weber, "As the CEO/founder of ProNES, my priority has always been to serve our customers and provide them with the best possible experience. Joining forces with Averna will enable us to better serve our customers worldwide and offer them an even broader range of test solutions. I am also convinced that it will bring our employees more opportunities to learn, grow, and advance their careers. I am excited about the future and the opportunities that this partnership will bring."

Averna's main shareholders Walter Capital Partners, Investissement Québec and W Investments Group LP, participated in the negotiation of this acquisition. This investment is consistent with their objective to further the international expansion of high-performing Quebec companies.

For more information on Averna, please visit their website.

About Averna

As a global Test & Quality Solution integrator, Averna partners with product designers, developers, and OEMs to help them achieve higher product quality, accelerate time to market and protect their brands. Founded in 1999, Averna offers specialized expertise and innovative test, vision inspection, precision assembly and automated solutions that deliver substantial technical, financial and market benefits for clients in the medical devices & life sciences, consumer products, automotive/transport, industrials, telecom and other industries. Averna has offices around the world, numerous industry certifications such as ISO 9001:2015, ITAR registration, and is partnered with NI, Eclipse Automation, PI, Keysight Technologies and JOT Automation. www.averna.com

© Copyright 2023 Averna. All rights reserved. Information subject to change without notice. Averna is a trademark of Averna Technologies Inc.

Averna Expands Global Footprint into Germany.

Averna Technologies Inc. logo

Video - https://www.youtube.com/watch?v=AYiNFMTS_3M
Photo - https://mma.prnewswire.com/media/2081833/Averna_Technologies_Inc__Averna_Expands_Global_Footprint_into_Ge.jpg
Logo - https://mma.prnewswire.com/media/2081831/Averna_Technologies_Inc__Averna_Expands_Global_Footprint_into_Ge.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/averna-expands-global-footprint-into-germany-with-the-acquisition-of-prones-301830376.html

© 2023 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.